Cited by 103Cardiac Fibrosis and RemodelingCell death mechanisms and regulationCardiac Ischemia and Reperfusion

Apoptosis and heart failure: clinical relevance and therapeutic target

GARG, S, NARULA, J, CHANDRASHEKHAR, Y·2005·Journal of Molecular and Cellular Cardiology

Abstract

Heart failure is the final common pathway of diverse etiologies that are characterized by impaired systolic and/or diastolic function with high morbidity and mortality. An integral part of pathogenesis of heart failure is myocyte loss. The traditional explanation for myocyte loss was cell necrosis but over the last decade, there has been a surge of evidence affirming the role of apoptosis in genesis of heart failure. Studies have raised apoptosis from a 'histologic curiosity' to an exciting 'clinical target' that can be modulated to attenuate the progression of heart failure. This review will focus on the clinical relevance of apoptosis in human and experimental heart failure and identify some of the progress made in myocardial anti-apoptotic intervention.

Integrity signals

Registry

Crossref · 10.1016/j.yjmcc.2004.11.006

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Myocyte apoptosis has been suggested to be an important etiological component of heart failure, particularly in the transition from compensatory remodeling to heart failure, although this concept has been somewhat contentious.

    “Myocyte apoptosis has been suggested to be an important etiological component of heart failure, particularly in the transition from compensatory remodeling to heart failure (112), although this concept has been somewhat contentious (95, 189, 295, 301).”

    From Cardiac remodeling in obesity (2008) · cites this paper as [112]

Cites

Flagged first, then by citations

1 of the 77 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
GARG, S., NARULA, J., & CHANDRASHEKHAR, Y.
Affiliations
  • Drexel University (US)
  • University of California, Irvine Medical Center (US)
  • University of Minnesota (US)
Venue
Journal of Molecular and Cellular Cardiology
Publisher
Elsevier BV
Published
2005-01
Volume
38
Issue
1
Pages
73-79
ISSN
0022-2828 (ISSN-L)
OpenAlex
W2110058514
Cited by
103
References
77
Citations by year
2026: 2 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 4 · 2018: 1 · 2017: 6 · 2016: 5 · 2015: 3 · 2014: 8 · 2013: 3 · 2012: 7
FWCI
5.24
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Molecular and Cellular Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
Keywords
apoptosis, heart failure, cardiomyocyte loss, myocardial necrosis, anti-apoptotic therapy, heart failure pathogenesis, systolic dysfunction, diastolic dysfunction, therapeutic target
MeSH terms
Animals, Humans, Cardiomyopathies, Myocardial Reperfusion Injury, Apoptosis, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review